NHS watchdog approves ‘world’s most expensive drug’ that costs £2.6million a dose… and it will SAVE the health service money, say experts

The drug, made by a Philadelphia-based pharmaceutical company is the only treatment of its kind for haemophilia B a bleeding disorder which affects approximately 2,000 people in the UK.The drug, made by a Philadelphia-based pharmaceutical company is the only treatment of its kind for haemophilia B a bleeding disorder which affects approximately 2,000 people in the UK.Read MoreHealth News | Mail Online